The aim of this study was to investigate and compare the potential of radiomics analysis of CEM and DCE-MRI of the breast for the non-invasive differentiation of tumor invasiveness, hormone receptor status, and tumor grade in patients with primary breast cancer. The gene discussed is NR4A1; the disease is breast cancer.